International Assets Investment Management LLC Makes New $33,000 Investment in Cronos Group Inc. $CRON

International Assets Investment Management LLC purchased a new position in shares of Cronos Group Inc. (NASDAQ:CRON) in the 2nd quarter, Holdings Channel.com reports. The fund purchased 17,265 shares of the company’s stock, valued at approximately $33,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Aigen Investment Management LP acquired a new stake in shares of Cronos Group in the first quarter valued at about $35,000. Mraz Amerine & Associates Inc. acquired a new stake in shares of Cronos Group in the second quarter valued at about $57,000. Connor Clark & Lunn Investment Management Ltd. grew its stake in shares of Cronos Group by 53.7% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 47,800 shares of the company’s stock valued at $86,000 after buying an additional 16,700 shares in the last quarter. Jones Financial Companies Lllp grew its stake in shares of Cronos Group by 291.6% in the first quarter. Jones Financial Companies Lllp now owns 65,099 shares of the company’s stock valued at $118,000 after buying an additional 48,476 shares in the last quarter. Finally, Nuveen LLC acquired a new stake in shares of Cronos Group in the first quarter valued at about $341,000. 8.71% of the stock is currently owned by institutional investors and hedge funds.

Cronos Group Stock Performance

Shares of CRON opened at $2.52 on Friday. The company has a market capitalization of $964.88 million, a P/E ratio of 50.40 and a beta of 1.12. Cronos Group Inc. has a one year low of $1.60 and a one year high of $3.16. The stock has a 50-day moving average price of $2.57 and a 200 day moving average price of $2.19.

Cronos Group (NASDAQ:CRON) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.08). The business had revenue of $33.46 million during the quarter, compared to analysts’ expectations of $45.73 million. Cronos Group had a net margin of 14.19% and a negative return on equity of 3.78%. As a group, equities research analysts forecast that Cronos Group Inc. will post -0.03 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on CRON. Wall Street Zen upgraded Cronos Group from a “sell” rating to a “hold” rating in a research note on Saturday, August 30th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Cronos Group in a research note on Friday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has a consensus rating of “Sell”.

About Cronos Group

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.